M. Wenczl

Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations

Medicine, Oncology, Pharmacology +13

Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction

Magdolna Dank, J. Załuski, Carlo Barone et al. · Annals of Oncology · 2008 · 343 citations · Full text

Medicine, Oncology, Pharmacology +13

Cisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: A phase III trial

Thomas Brodowicz, Maciej Krzakowski, Matjaž Zwitter et al. · Lung Cancer · 2006 · 323 citations

Medicine, Oncology, Pharmacology +13

Adjuvant Hormone Therapy May Improve Survival in Epithelial Ovarian Cancer: Results of the AHT Randomized Trial

Rosalind A. Eeles, James P. Morden, Martin Gore et al. · Journal of Clinical Oncology · 2015 · 131 citations · Full text

Medicine, Gynecology, Oncology +17

Randomized phase 3 trial of irinotecan (CPT-11) + 5FU/folinic acid (FA) vs CDDP + 5FU in 1^st-line advanced gastric cancer patients

Magdolna Dank, J. Załuski, C. Barone et al. · Journal of Clinical Oncology · 2005 · 87 citations

Medicine, Oncology, Pharmacology +5